Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1992 Oct;44(4):537-53.
doi: 10.2165/00003495-199244040-00002.

Diabetic gastroparesis. A critical reappraisal of new treatment strategies

Affiliations
Review

Diabetic gastroparesis. A critical reappraisal of new treatment strategies

J P Drenth et al. Drugs. 1992 Oct.

Abstract

Delayed gastric emptying, gastroparesis, is one of the sequelae of diabetes mellitus. Symptoms may include postprandial nausea, epigastric pain, bloating, vomiting, early satiety and unpredictable blood sugar fluctuations. Nowadays diagnosis is made by the measurement of gastric emptying with a radionuclide test meal. Using this technique some 50% of diabetic patients show signs of disordered gastric emptying. Relief is best delivered by agents promoting gastric emptying. In phase II single-dose studies metoclopramide, domperidone, cisapride, erythromycin and renzapride were all able to enhance gastric evacuation of solid and liquid meals in patients with diabetic gastroparesis. A few short term studies support the efficacy of domperidone and renzapride, but long term trials are lacking. Erythromycin, mimicking the potent gastrokinetic effect of motilin, may hold considerable promise for the future. Experience with erythromycin in diabetic gastroparesis is nonetheless very limited. To some extent the therapeutic effectiveness of metoclopramide and cisapride has been established in placebo-controlled trials. In trials with a placebo-controlled crossover design, however, only metoclopramide showed a sustained positive effect. Metoclopramide, which combines gastrokinetic and antiemetic properties seems, so far, the best therapeutic option in diabetic gastroparesis. Cisapride may be considered as a good alternative in cases where limited efficacy or side effects preclude the use of metoclopramide.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Drugs. 1992 Mar;43(3):295-315 - PubMed
    1. Clin Pharm. 1990 May;9(5):357-65 - PubMed
    1. Am J Med Sci. 1985 Jun;289(6):240-2 - PubMed
    1. Am J Gastroenterol. 1989 Nov;84(11):1351-5 - PubMed
    1. Scand J Gastroenterol. 1991 Jul;26(7):673-84 - PubMed

MeSH terms